DEAR DR. ROACH: I recently brought myself to the hospital because my electrocardiogram (EKG) result showed “possible ischemia ...

A shift in the beta-blocker treatment paradigm has arrived with the changing myocardial infarction treatment landscape, said ...

In the ABYSS trial, researchers found that interrupting a beta-blocker in patients after a myocardial infarction resulted in ...

Young patients with myocardial infarction (MI) and fewer traditional risk factors often have greater exposure to urban noise, ...

Percutaneous coronary intervention (PCI) has proven lifesaving: Morbidity and mortality outcomes are significantly improved ...

Several firms are bringing high-sensitivity cardiac troponin testing into the ER, although doctors are not yet certain how ...

Long-term use of beta-blockers in patients with myocardial infarction and preserved heart function does not significantly ...

During a massive heart attack, a large portion of the heart doesn’t receive oxygen due to a blocked artery. Quick treatment ...

JPI-289 is under clinical development by Jeil Pharmaceutical and currently in Phase II for Myocardial Infarction.

Background In acute heart failure (HF), reduced cardiac output, vasoconstriction and congestion may damage the intestinal ...

In a large meta-analysis, complete revascularisation reduced cardiovascular events compared with culprit-only revascularisation in older patients with a myocardial infarction and multivessel disease ...

BACKGROUND: Cardiac troponin (cTn) is key in diagnosing myocardial infarction (MI). After MI, the clinically observed half-life of cTn has been reported to be 7 to 20 hours, but this estimate reflects ...